With so many sites promising big wins, endless entertainment and being the best online casino Australia has to offer, it’s ...

A combination of encorafenib and binimetinib nearly doubled survival for patients with BRAF V600E–mutated non-small cell lung cancer when used as initial therapy, investigators reported at the ...

The venetoclax and obinutuzumab combination showed high efficacy in Japanese CLL/SLL patients, achieving a 90% complete remission rate and 100% overall response rate. A 100% undetectable minimal ...

Forbes contributors publish independent expert analyses and insights. I write about TV shows, movies, video games, entertainment & culture. It’s a big week for new TV shows, though the majority of the ...

R-MPV plus Imbruvica achieved a 97% complete response rate in newly diagnosed PCNSL patients, with a 100% overall response rate and no refractory cases. The two-year progression-free survival rate was ...

Sac-TMT combined with Keytruda significantly improves progression-free survival in PD-L1-positive advanced non-small cell lung cancer. The OptiTROP-Lung05 study is the first phase 3 trial of an ...

What a year for new shows. As TV Guide narrowed down our favorite series of 2025, what stood out was how many of them — more than half — premiered this year. And not one of those new shows is part of ...